Litcius/Paper detail

Albendazole inhibits NF-κB signaling pathway to overcome tumor stemness and bortezomib resistance in multiple myeloma

Hui Yi, Long Liang, Haiqin Wang, Saiqun Luo, Hu Lei, Yanpeng Wang, Xiaokai Shen, Ling Xiao, Yibin Zhang, Hongling Peng, Chong-Wen Dai, Lingli Yuan, Ruijuan Li, Fanjie Gong, Zhenzhen Li, Mao Ye, Jing Liu, Hui Zhou, Ji Zhang, Xiaojuan Xiao

2021Cancer Letters43 citationsDOI

Topics & Concepts

BortezomibMultiple myelomaAldehyde dehydrogenaseCancer researchIn vivoMedicinePharmacologyDrug resistanceStem cellImmunologyBiologyCell biologyMicrobiologyBiochemistryGeneBiotechnologyMultiple Myeloma Research and TreatmentsCancer Mechanisms and TherapyHistone Deacetylase Inhibitors Research
Albendazole inhibits NF-κB signaling pathway to overcome tumor stemness and bortezomib resistance in multiple myeloma | Litcius